CJC-1295 (DAC)

Long-acting GHRH analogue with Drug Affinity Complex

CJC-1295 with Drug Affinity Complex features a maleimidoproprionic acid linker enabling covalent albumin binding, extending its half-life in research models. Extensively referenced in preclinical GH research.

Research Applications

Extended half-life studies

Sustained GH elevation models

Albumin-binding research

Long-acting GHRH research

For Research Use Only — Not for Human Consumption

Select Size

Price excl. VAT

26,96 €

51 in stock

VAT (20%) × 1+5,39 €

Total incl. VAT32,35 €

CJC-DAC-2MG

Store at −20 °C.